
Asensus Surgical
Asensus Surgical (formerly TransEnterix) is advancing performance-guided surgery with its Senhance Surgical System, using machine vision, augmented intelligence, and deep learning to enhance surgeon control, reduce variability, and improve outcomes.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
N/A | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | N/A | Acquisition | |
Total Funding | 000k |














USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | (65 %) | (63 %) | 159 % | (14 %) | 21 % | 43 % | 81 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (934 %) | (1354 %) | (610 %) | (895 %) | (866 %) | - | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (1808 %) | (1868 %) | (759 %) | (1066 %) | (914 %) | - | - |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 263 % | 523 % | 235 % | 408 % | 432 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Asensus Surgical is a pioneering company in the field of digital surgical technology, specializing in robotic-assisted procedures. The company serves healthcare providers, particularly surgeons, by offering advanced tools that enhance the safety and predictability of surgeries. Operating in the medical technology market, Asensus leverages its proprietary Augmented Intelligence system to provide real-time, actionable insights during surgeries. This system integrates innovative digital tools with advanced surgical robotics, aiming to make complex surgeries more accessible and safer. The business model revolves around selling these high-tech surgical systems and providing ongoing support and updates, generating revenue through both initial sales and recurring service contracts. Asensus is at the forefront of transforming surgical procedures, making them more efficient and reliable.
Keywords: digital surgical technology, robotic-assisted procedures, healthcare, Augmented Intelligence, real-time insights, advanced tools, safety, predictability, medical technology, surgical systems.
Tech stack
Investments by Asensus Surgical
Edit